当前位置:首页 - 行情中心 - 千金药业(600479) - 财务分析 - 现金流量表

千金药业

(600479)

  

流通市值:44.78亿  总市值:44.78亿
流通股本:4.19亿   总股本:4.19亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,755,790,068.27857,770,105.893,627,441,267.882,753,684,047.01
  收到其他与经营活动有关的现金84,855,239.2535,031,976.98411,101,607.36183,600,811.95
  经营活动现金流入小计1,840,645,307.52892,802,082.874,038,542,875.242,937,284,858.96
  购买商品、接受劳务支付的现金765,441,144.73375,536,869.181,572,260,744.851,319,427,662.27
  支付给职工以及为职工支付的现金416,373,620.7270,570,301.7734,713,852.84583,836,070.49
  支付的各项税费197,025,380.5976,169,912.27347,785,345.1270,049,779.57
  支付其他与经营活动有关的现金506,272,231294,893,912.85985,016,477.85714,873,673.61
  经营活动现金流出小计1,885,112,377.021,017,170,9963,639,776,420.642,888,187,185.94
  经营活动产生的现金流量净额-44,467,069.5-124,368,913.13398,766,454.649,097,673.02
二、投资活动产生的现金流量:
  收回投资收到的现金2,400,0002,400,000-1,069,490.2
  取得投资收益收到的现金117,000-5,746,5005,746,500
  处置固定资产、无形资产和其他长期资产收回的现金净额205,500-391,520.76-
  投资活动现金流入小计2,722,5002,400,0006,138,020.766,815,990.2
  购建固定资产、无形资产和其他长期资产支付的现金35,957,906.494,269,256.2647,320,542.8233,501,046.59
  投资支付的现金390,000,000290,000,000700,000,0001,069,490.2
  投资活动现金流出小计425,957,906.49294,269,256.26747,320,542.8234,570,536.79
  投资活动产生的现金流量净额-423,235,406.49-291,869,256.26-741,182,522.06-27,754,546.59
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金5,594,632.232,000,00016,282,452.37-
  筹资活动现金流入平衡项目000-
  筹资活动现金流入小计5,594,632.232,000,00016,282,452.37-
  偿还债务支付的现金3,000,000-46,945,683.7533,945,683.75
  分配股利、利润或偿付利息支付的现金4,892,421.01240,000180,456,290.34175,910,851.61
  其中:子公司支付给少数股东的股利、利润4,840,000240,00027,641,083.0420,043,483.04
  支付其他与筹资活动有关的现金16,555,920-39,001,798.5116,539,280
  筹资活动现金流出小计24,448,341.01240,000266,403,772.6226,395,815.36
  筹资活动产生的现金流量净额-18,853,708.781,760,000-250,121,320.23-226,395,815.36
五、现金及现金等价物净增加额-486,556,184.77-414,478,169.39-592,537,387.69-205,052,688.93
  加:期初现金及现金等价物余额1,335,794,750.51,335,794,750.51,928,332,138.191,928,332,138.19
  期末现金及现金等价物余额849,238,565.73921,316,581.111,335,794,750.51,723,279,449.26
补充资料:
  净利润174,035,961.39-302,608,701.01-
  资产减值准备2,038,165.9-7,823,288.98-
  固定资产和投资性房地产折旧28,962,072.51-64,575,449.53-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧28,962,072.51-64,575,449.53-
  无形资产摊销7,165,553.96-13,346,669.42-
  长期待摊费用摊销8,460,032.57-20,900,169.73-
  处置固定资产、无形资产和其他长期资产的损失-8,827.08--497,372.67-
  固定资产报废损失123,399.66-451,507.58-
  公允价值变动损失-1,372,771.77--634,598.12-
  财务费用36,566.67-4,146,232.03-
  投资损失-18,803,638.62--15,582,312.28-
  递延所得税-2,556,479.55--1,363,127.55-
  其中:递延所得税资产减少-5,912,925.48-5,693,151.56-
    递延所得税负债增加3,356,445.93--7,056,279.11-
  存货的减少44,537,350.31-44,607,230.46-
  经营性应收项目的减少-361,639,594.53-18,729,574.94-
  经营性应付项目的增加52,380,038.56--147,803,143.32-
  其他--60,884,469.84-
  现金的期末余额849,238,565.73-1,335,794,750.5-
  减:现金的期初余额1,335,794,750.5-1,928,332,138.19-
  现金及现金等价物的净增加额-486,556,184.77--592,537,387.69-
公告日期2025-08-302025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑